A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration
Clinical trial NCT05230537 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05230537
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-17
- Primary completion
- 2026-10-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.